Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IFNA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KLHL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RASSF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35G1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM63B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3C3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00488 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NECAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on